These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6813205)

  • 1. [Effect of d-pseudoephedrine on the central nervous system in mice].
    Akiba K; Satoh S; Matsumura H; Suzuki T; Kohno H; Tadano T; Kisara K
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):401-8. PubMed ID: 6813205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological action of pseudoephedrine salicylate on the central nervous system of mice].
    Yan L; Jin SJ; Wang R; Jiang YX; Liu LJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):665-7. PubMed ID: 15460414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of reverse tolerance to the ambulation-increasing effect of ephedrine after repeated administration in mice].
    Hirabayashi M; Okada S
    Yakubutsu Seishin Kodo; 1985 Sep; 5(3):231-41. PubMed ID: 4072434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
    Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
    Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some central nervous system actions of 5-(3 dimethylamino-2-methyl-propyl) dibenzo [a, d] [1,4] cyclooctadiene hydrochloride.
    Raina RK; Sharma JD
    Indian J Physiol Pharmacol; 1974; 18(4):349-54. PubMed ID: 4143134
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereospecificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA).
    Vapaatalo H; Onken D; Neuvonen PJ; Westermann E
    Arzneimittelforschung; 1975 Mar; 25(3):407-10. PubMed ID: 1174042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system activity of yangambin from Ocotea duckei Vattimo (Lauraceae) in mice.
    de Sousa FC; Pereira BA; Lima VT; Lacerda CD; Melo CT; Barbosa-Filho JM; Vasconcelos SM; Viana GS
    Phytother Res; 2005 Apr; 19(4):282-6. PubMed ID: 16041767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinosin, a C-glycoside flavonoid from semen Zizhiphi Spinozae, potentiated pentobarbital-induced sleep via the serotonergic system.
    Wang LE; Bai YJ; Shi XR; Cui XY; Cui SY; Zhang F; Zhang QY; Zhao YY; Zhang YH
    Pharmacol Biochem Behav; 2008 Sep; 90(3):399-403. PubMed ID: 18466960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological studies of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone (M73101). (5) Action of M73101 on the central nervous system (author's transl)].
    Sato M
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):695-706. PubMed ID: 575516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of N,N'-diallylpentobarbital potentiation of pentobarbital-induced sleep in mice.
    Tateoka Y; Kimura T; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):173-85. PubMed ID: 3659568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration of a depressive component in the central effects of nikethamide].
    Buchel L; Absil J
    Arch Sci Physiol (Paris); 1972; 26(2):175-94. PubMed ID: 4265482
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic assessment of tolerance to pentobarbital by pellet implantation.
    Ho IK
    J Pharmacol Exp Ther; 1976 Jun; 197(3):479-87. PubMed ID: 932988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of central stimulating effects between ephedrine and apomorphine].
    Li Q; Li BH
    Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):468-71. PubMed ID: 1819906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of reserpine and syrosingopine upon pentobarbital depression.
    Ponessa JT; De Boer B
    Arch Int Pharmacodyn Ther; 1966 Nov; 164(1):67-70. PubMed ID: 4382038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.